Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Depreciation & Amortization (CF) (2016 - 2026)

Viridian Therapeutics, Inc.\DE has reported Depreciation & Amortization (CF) over the past 12 years, most recently at $120000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $120000.0 for Q4 2025, up 44.58% from a year ago — trailing twelve months through Dec 2025 was $460000.0 (down 8.0% YoY), and the annual figure for FY2025 was $460000.0, down 8.0%.
  • Depreciation & Amortization (CF) for Q4 2025 was $120000.0 at Viridian Therapeutics, Inc.\DE, up from $110000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for VRDN hit a ceiling of $145000.0 in Q1 2024 and a floor of $25000.0 in Q2 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $111500.0 (2025), compared with a mean of $94000.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 60.94% in 2021 and later skyrocketed 340.62% in 2022.
  • Viridian Therapeutics, Inc.\DE's Depreciation & Amortization (CF) stood at $32000.0 in 2021, then skyrocketed by 340.62% to $141000.0 in 2022, then dropped by 9.22% to $128000.0 in 2023, then crashed by 35.16% to $83000.0 in 2024, then soared by 44.58% to $120000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $120000.0 (Q4 2025), $110000.0 (Q3 2025), and $113000.0 (Q2 2025) per Business Quant data.